Skip to content

Effect of prenatal fetal surveillance on neonatal outcomes in diabetic pregnant patients

lnvestigation on effect of prenatal fetal surveillance on neonatal outcomes in diabetic pregnant patients: a diagnostic trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20200127046278N1
Enrollment
110
Registered
2023-08-25
Start date
2021-10-11
Completion date
Unknown
Last updated
2023-10-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes in pregnancy. Diabetes mellitus in pregnancy

Interventions

Intervention 1: Biophysical intervention group: Patients will be subjected to weekly biophysical evaluation after 36 weeks. In this method, fetal movement, fetal breathing, and amniotic fluid volume a

Sponsors

Tehran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: Diabetic pregnant patients who recieve oral medication or insulin therapy Gestational age> 28weeks Consent to participate

Exclusion criteria

Exclusion criteria: History of chronic diseases, including endocrine diseases (Except diabetes) History of corticosteroid use Vascular complications of diabetes

Design outcomes

Primary

MeasureTime frame
5th minute apgar score. Timepoint: after birth. Method of measurement: examination.;Admission to neonatal intensive care unit (NICU). Timepoint: 1 months after birth. Method of measurement: Clinical Records.

Secondary

MeasureTime frame
Birth weight. Timepoint: After birth. Method of measurement: Weight scale.;Birth height. Timepoint: After birth. Method of measurement: Meter.;Macrosomia Incidence. Timepoint: After birth. Method of measurement: Physical exam.;Incidence of small for gestational age (SGA). Timepoint: After birth. Method of measurement: Physical exam.;Hypoglycemia incidence. Timepoint: After birth. Method of measurement: Lab test.;Hyperbilirubinemia incidence. Timepoint: After birth. Method of measurement: Lab test.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactZeinab Mansouri

Tehran University of Medical Sciences

z_mansouri88@yahoo.com+98 21 6119 0000

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026